Shop MDUK Professionals

Helpline 0800 652 6352

Helpline 0800 652 6352

NEWS and UPDATES

Early laboratory studies have shown a small molecule called MZ-101 can reduce the harmful buildup of glycogen found in the muscle cells of people living with Pompe disease. Evidence so far suggests that combining the use of this molecule and existing enzyme replacement therapy (ERT) may be a more effective way of treating the condition.

ALL NEWS

Filter by type

A potential treatment for Pompe disease shows future promise

Sporting stars show support at Celebrity Sports Quiz

The latest research into muscle wasting conditions at the UK Neuromuscular Translational Research Conference

New partnership blooms with Blue Diamond Garden Centres

Thousands complete Bidwells Oxford 10k to raise £300,000

Givinostat – our role in supporting access to new treatments

Building a legacy: Over £8 million raised by property sector fundraising event

Our auction for London’s hottest ticket: You Me Bum Bum Train

Accelerating the development of treatments for congenital muscular dystrophy – our £1 million partnership with LifeArc

New drug in development for primary mitochondrial myopathies

New Muscle Groups dates announced

We’re calling on the UK Government to tackle the challenges faced by people with muscle wasting and weakening conditions in its upcoming 10 Year Health Plan